265. 脂肪萎縮症 Lipodystrophy Clinical trials / Disease details
臨床試験数 : 112 / 薬物数 : 155 - (DrugBank : 55) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 97
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01788462 (ClinicalTrials.gov) | May 2012 | 1/2/2013 | Egrifta Replacement and Sleep Disordered Breathing | Egrifta Replacement and Sleep Disordered Breathing | Lipodystrophy | Drug: Tesamorelin (Egrifta) | Johns Hopkins University | NULL | Withdrawn | 18 Years | 75 Years | All | 0 | N/A | United States |